{"pub": "marketwatch", "url": "https://marketwatch.com/articles/bristol-myers-squibb-earnings-preview-51572382881", "downloaded_at": "2019-10-30 10:48:21.851014+00:00", "title": "Bristol-Myers Squibb Reports Earnings Tomorrow. Here\u2019s What to Expect.", "language": "en", "text": "After a disastrous first half of the year, Bristol-Myers Squibb has staged a surprising recovery. On Thursday, investors will have a chance to assess whether the rally should continue as the drugmaker releases its third-quarter results.\n\nThe stock is up 23% since the beginning of July, vastly outperforming the S&P 500, which was up 3.2% over the same period. Still, the surge comes after a dreary March and April: The stock is up only 7.3% so far this year, trailing behind the S&P 500, which has risen 21.1%.\n\n...", "description": "Bristo-Mayers Squibb has staged a surprising recovery. On Thursday, investors will have a chance to assess whether the rally should continue as the drugmaker releases its third-quarter results.", "authors": ["Josh Nathan-Kazis"], "top_image": "https://asset.barrons.com/public/resources/images/ON-DH409_BMY103_OR_20191029143930.jpg", "published_at": "2019-10-30"}